Skip to content

Biohaven BHVN Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$88K
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's unrealized gains on investments?
Biohaven (BHVN) reported unrealized gains on investments of $2K in Q1 2026.
How has Biohaven's unrealized gains on investments changed year-over-year?
Biohaven's unrealized gains on investments decreased by 97.2% year-over-year, from $71K to $2K.
What is the long-term trend for Biohaven's unrealized gains on investments?
Over 3 years (2022 to 2025), Biohaven's unrealized gains on investments has grown at a 6.1% compound annual growth rate (CAGR), from $51K to $61K.